{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:05:57Z","timestamp":1790661957786,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,4,7]],"date-time":"2006-04-07T00:00:00Z","timestamp":1144368000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2006,6,6]]},"DOI":"10.1007\/s00198-006-0091-4","type":"journal-article","created":{"date-parts":[[2006,4,6]],"date-time":"2006-04-06T11:37:49Z","timestamp":1144323469000},"page":"1103-1110","source":"Crossref","is-referenced-by-count":19,"title":["Negative correlation between bone mineral density and TSH receptor antibodies in male patients with untreated Graves\u2019 disease"],"prefix":"10.1007","volume":"17","author":[{"given":"T.","family":"Majima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Shigemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fukao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Corners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,4,7]]},"reference":[{"key":"91_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-6009(08)80115-8","volume":"21","author":"MM Campos-Pastor","year":"1993","unstructured":"Campos-Pastor MM, Munoz-Torres M, Escobar-Jimenez F, Ruiz de Almodovar M, Jodar Gimeno E (1993) Bone mass in females with different thyroid disorders: influence of menopausal status. Bone Miner 21:1\u20138","journal-title":"Bone Miner"},{"key":"91_CR2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-120-1-199401010-00002","volume":"120","author":"T Diamond","year":"1994","unstructured":"Diamond T, Vine J, Smart R, Butler P (1994) Thyrotoxic bone disease in women: a potentially reversible disorder. Ann Intern Med 120:8\u201311","journal-title":"Ann Intern Med"},{"key":"91_CR3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s001980050091","volume":"8","author":"C Gomez Acotto","year":"1998","unstructured":"Gomez Acotto C, Schott AM, Hans D, Niepomniszcze H, Mautalen CA, Meunier PJ (1998) Hyperthyroidism influences ultrasound bone measurement on the Os calcis. Osteoporos Int 8:455\u2013459","journal-title":"Osteoporos Int"},{"key":"91_CR4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2265.1999.00626.x","volume":"50","author":"M Olkawa","year":"1999","unstructured":"Olkawa M, Kushida K, Takahashi M, Ohishi T, Hoshino H, Suzuki M, Ogihara H, Ishigaki J, Inoue T (1999) Bone turnover and cortical bone mineral density in the distal radius in patients with hyperthyroidism being treated with antithyroid drugs for various periods of time. Clin Endocrinol (Oxf) 50:171\u2013176","journal-title":"Clin Endocrinol (Oxf)"},{"key":"91_CR5","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1359\/jbmr.1999.14.10.1664","volume":"14","author":"S Mora","year":"1999","unstructured":"Mora S, Pitukcheewanont P, Kaufman FR, Nelson JC, Gilsanz V (1999) Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development. J Bone Miner Res 14:1664\u20131671","journal-title":"J Bone Miner Res"},{"key":"91_CR6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0378-5122(00)00179-1","volume":"39","author":"A Ben-Shlomo","year":"2001","unstructured":"Ben-Shlomo A, Hagag P, Evans S, Weiss M (2001) Early postmenopausal bone loss in hyperthyroidism. Maturitas 39:19\u201327","journal-title":"Maturitas"},{"key":"91_CR7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2265.2004.02110.x","volume":"61","author":"H Karga","year":"2004","unstructured":"Karga H, Papapetrou PD, Korakovouni A, Papandroulaki F, Polymeris A, Pampouras G (2004) Bone mineral density in hyperthyroidism. Clin Endocrinol (Oxf) 61:466\u2013472","journal-title":"Clin Endocrinol (Oxf)"},{"key":"91_CR8","doi-asserted-by":"crossref","first-page":"750","DOI":"10.7326\/0003-4819-130-9-199905040-00016","volume":"130","author":"SL Greenspan","year":"1999","unstructured":"Greenspan SL, Greenspan FS (1999) The effect of thyroid hormone on skeletal integrity. Ann Intern Med 130:750\u2013758","journal-title":"Ann Intern Med"},{"key":"91_CR9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1359\/jbmr.1997.12.1.72","volume":"12","author":"C Marcocci","year":"1997","unstructured":"Marcocci C, Golia F, Vignali E, Pinchera A (1997) Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine. J Bone Miner Res 12:72\u201377","journal-title":"J Bone Miner Res"},{"key":"91_CR10","first-page":"2324","volume":"83","author":"HN Rosen","year":"1998","unstructured":"Rosen HN, Moses AC, Garber J, Ross DS, Lee SL, Ferguson L, Chen V, Lee K, Greenspan SL (1998) Randomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate. J Clin Endocrinol Metab 83:2324\u20132330","journal-title":"J Clin Endocrinol Metab"},{"key":"91_CR11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s002230020041","volume":"69","author":"E Jodar","year":"2001","unstructured":"Jodar E, Martinez-Diaz-Guerra G, Azriel S, Hawkins F (2001) Bone mineral density in male patients with L-thyroxine suppressive therapy and Graves disease. Calcif Tissue Int 69:84\u201387","journal-title":"Calcif Tissue Int"},{"key":"91_CR12","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM198606263142605","volume":"26","author":"BL Riggs","year":"1986","unstructured":"Riggs BL, Melton LJ 3rd (1986) Involutional osteoporosis. N Engl J Med 26:1676\u20131686","journal-title":"N Engl J Med"},{"key":"91_CR13","doi-asserted-by":"crossref","unstructured":"Mosekilde L, Eriksen EF, Charles P (1990) Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 19:35\u201363","DOI":"10.1016\/S0889-8529(18)30338-4"},{"key":"91_CR14","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1210\/jcem-70-3-766","volume":"70","author":"MS Lee","year":"1990","unstructured":"Lee MS, Kim SY, Lee MC, Cho BY, Lee HK, Koh CS, Min HK (1990) Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. J Clin Endocrinol Metab 70:766\u2013770","journal-title":"J Clin Endocrinol Metab"},{"key":"91_CR15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2265.1993.tb01007.x","volume":"38","author":"M Wakasugi","year":"1993","unstructured":"Wakasugi M, Wakao R, Tawata M, Gan N, Koizumi K, Onaya T (1993) Bone mineral density in patients with hyperthyroidism measured by dual energy X-ray absorptiometry. Clin Endocrinol (Oxf) 38:283\u2013286","journal-title":"Clin Endocrinol (Oxf)"},{"key":"91_CR16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2265.1997.2261041.x","volume":"47","author":"E Jodar","year":"1997","unstructured":"Jodar E, Munoz-Torres M, Escobar-Jimenez F, Quesada-Charneco M, Lund del Castillo JD (1997) Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause. Clin Endocrinol (Oxf) 47:279\u2013285","journal-title":"Clin Endocrinol (Oxf)"},{"key":"91_CR17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2265.1992.tb02280.x","volume":"37","author":"AH Mudde","year":"1992","unstructured":"Mudde AH, Reijnders FJ, Kruseman AC (1992) Peripheral bone density in women with untreated multinodular goitre. Clin Endocrinol (Oxf) 37:35\u201339","journal-title":"Clin Endocrinol (Oxf)"},{"key":"91_CR18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(71)91383-3","volume":"1","author":"SA Fraser","year":"1971","unstructured":"Fraser SA, Anderson JB, Smith DA, Wilson GM (1971) Osteoporosis and fractures following thyrotoxicosis. Lancet 1:981\u2013983","journal-title":"Lancet"},{"key":"91_CR19","first-page":"4157","volume":"85","author":"Y Kumeda","year":"2000","unstructured":"Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, Nishizawa Y (2000) Persistent increase in bone turnover in Graves\u2019 patients with subclinical hyperthyroidism. J Clin Endocrinol Metab 85:4157\u20134161","journal-title":"J Clin Endocrinol Metab"},{"key":"91_CR20","first-page":"753","volume":"82","author":"A Siddiqi","year":"1997","unstructured":"Siddiqi A, Burrin JM, Noonan K, James I, Wood DF, Price CP, Monson JP (1997) A longitudinal study of markers of bone turnover in Graves\u2019 disease and their value in predicting bone mineral density. J Clin Endocrinol Metab 82:753\u2013759","journal-title":"J Clin Endocrinol Metab"},{"key":"91_CR21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1067\/mpd.2000.106219","volume":"137","author":"N Lucidarme","year":"2000","unstructured":"Lucidarme N, Ruiz JC, Czernichow P, Leger J (2000) Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves\u2019 disease. J Pediatr 137:56\u201362","journal-title":"J Pediatr"},{"key":"91_CR22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1081\/ERC-120026945","volume":"29","author":"B Ugur-Altun","year":"2003","unstructured":"Ugur-Altun B, Altun A, Arikan E, Guldiken S, Tugrul A (2003) Relationships existing between the serum cytokine levels and bone mineral density in women in the premenopausal period affected by Graves\u2019 disease with subclinical hyperthyroidism. Endocr Res 29:389\u2013398","journal-title":"Endocr Res"},{"key":"91_CR23","first-page":"98","volume":"25","author":"MR Fittipaldi","year":"2002","unstructured":"Fittipaldi MR, Fonderico F, Vitale G, Ciccarelli A, Lupoli GA, Cascella T, Panico A, Lupoli G (2002) Osteoporosis treatment in elderly hyperthyroid male patients. J Endocrinol Invest 25:98\u2013100","journal-title":"J Endocrinol Invest"},{"key":"91_CR24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archinte.1985.00360050147025","volume":"145","author":"SH Toh","year":"1985","unstructured":"Toh SH, Claunch BC, Brown PH (1985) Effect of hyperthyroidism and its treatment on bone mineral content. Arch Intern Med 145:883\u2013886","journal-title":"Arch Intern Med"},{"key":"91_CR25","first-page":"3431","volume":"84","author":"JP Bilezikian","year":"1999","unstructured":"Bilezikian JP (1999) Osteoporosis in men. J Clin Endocrinol Metab 84:3431\u20133434","journal-title":"J Clin Endocrinol Metab"},{"key":"91_CR26","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/endo.139.5.5992","volume":"139","author":"M Milne","year":"1998","unstructured":"Milne M, Kang MI, Quail JM, Baran DT (1998) Thyroid hormone excess increases insulin-like growth factor I transcripts in bone marrow cell cultures: divergent effects on vertebral and femoral cell cultures. Endocrinology 139:2527\u20132534","journal-title":"Endocrinology"},{"key":"91_CR27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/thy.2000.10.341","volume":"10","author":"P Vestergaard","year":"2000","unstructured":"Vestergaard P, Rejnmark L, Weeke J, Mosekilde L (2000) Fracture risk in patients treated for hyperthyroidism. Thyroid 10:341\u2013348","journal-title":"Thyroid"},{"key":"91_CR28","doi-asserted-by":"crossref","unstructured":"Vestergaard P, Mosekilde L (2002) Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid 12:411\u2013419","DOI":"10.1089\/105072502760043503"},{"key":"91_CR29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/105072503322238854","volume":"13","author":"P Vestergaard","year":"2003","unstructured":"Vestergaard P, Mosekilde L (2003) Hyperthyroidism, bone mineral, and fracture risk-a meta-analysis. Thyroid 13:585\u2013593","journal-title":"Thyroid"},{"key":"91_CR30","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","volume":"332","author":"SR Cummings","year":"1995","unstructured":"Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995) Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332:767\u2013773","journal-title":"N Engl J Med"},{"key":"91_CR31","doi-asserted-by":"crossref","unstructured":"Wejda B, Hintze G, Katschinski B, Olbricht T, Benker G (1995) Hip fractures and the thyroid: a case-control study. J Intern Med 237:241\u2013247","DOI":"10.1111\/j.1365-2796.1995.tb01172.x"},{"key":"91_CR32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0092-8674(03)00771-2","volume":"115","author":"E Abe","year":"2003","unstructured":"Abe E, Marians RC, Yu W, Wu XB, Ando T, Li Y, Iqbal J, Eldeiry L, Rajendren G, Blair HC, Davies TF, Zaidi M (2003) TSH is a negative regulator of skeletal remodeling. Cell 115:151\u2013162","journal-title":"Cell"},{"key":"91_CR33","doi-asserted-by":"crossref","unstructured":"Morimura T, Tsunekawa K, Kasahara T, Seki K, Ogiwara T, Mori M, Murakami M (2005) Expression of type 2 iodothyronine deiodinase in human osteoblast is stimulated by thyrotropin. Endocrinology 146:2077\u20132084","DOI":"10.1210\/en.2004-1432"},{"key":"91_CR34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0002-9343(91)90066-7","volume":"91","author":"SL Greenspan","year":"1991","unstructured":"Greenspan SL, Greenspan FS, Resnick NM, Block JE, Friedlander AL, Genant HK (1991) Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy. Am J Med 91:5\u201314","journal-title":"Am J Med"},{"key":"91_CR35","first-page":"2986","volume":"81","author":"O Torring","year":"1996","unstructured":"Torring O, Tallstedt L, Wallin G, Lundell G, Ljunggren JG, Taube A, Saaf M, Hamberger B (1996) Graves\u2019 hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine\u2013a prospective, randomized study. Thyroid Study Group. J Clin Endocrinol Metab 81:2986\u20132993","journal-title":"J Clin Endocrinol Metab"},{"key":"91_CR36","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1210\/jc.2003-030430","volume":"88","author":"LJ Brokken","year":"2003","unstructured":"Brokken LJ, Wiersinga WM, Prummel MF (2003) Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves\u2019 disease patients. J Clin Endocrinol Metab 88:4135\u20134138","journal-title":"J Clin Endocrinol Metab"},{"key":"91_CR37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/s-2003-44704","volume":"111","author":"R Schneider","year":"2003","unstructured":"Schneider R, Reiners C (2003) The effect of levothyroxine therapy on bone mineral density: a systematic review of the literature. Exp Clin Endocrinol Diabetes 111:455\u2013470","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"91_CR38","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1210\/endo.142.10.8445","volume":"142","author":"JM Fitts","year":"2001","unstructured":"Fitts JM, Klein RM, Powers CA (2001) Estrogen and tamoxifen interplay with T(3) in male rats: pharmacologically distinct classes of estrogen responses affecting growth, bone, and lipid metabolism, and their relation to serum GH and IGF-I. Endocrinology 142:4223\u20134235","journal-title":"Endocrinology"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-006-0091-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-006-0091-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-006-0091-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:04:00Z","timestamp":1558609440000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-006-0091-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,6,6]]}},"alternative-id":["91"],"URL":"https:\/\/doi.org\/10.1007\/s00198-006-0091-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,7]]}}}